• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of mepolizumab on the sputum level of eosinophil-derived protein in three cases of severe asthma.

作者信息

Koya Toshiyuki, Kimura Yosuke, Hayashi Masachika, Hasegawa Takashi, Kikuchi Toshiaki

机构信息

Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

出版信息

Allergol Int. 2020 Oct;69(4):639-641. doi: 10.1016/j.alit.2020.03.009. Epub 2020 May 19.

DOI:10.1016/j.alit.2020.03.009
PMID:32439281
Abstract
摘要

相似文献

1
The impact of mepolizumab on the sputum level of eosinophil-derived protein in three cases of severe asthma.美泊利珠单抗对3例重度哮喘患者痰液嗜酸性粒细胞衍生蛋白水平的影响。
Allergol Int. 2020 Oct;69(4):639-641. doi: 10.1016/j.alit.2020.03.009. Epub 2020 May 19.
2
Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab.针对白细胞介素-5 信号通路的抗体作为严重嗜酸性粒细胞性哮喘患者的附加治疗药物：皮下给予美泊利珠单抗和贝那利珠单抗的作用机制、疗效和安全性的综述。
Expert Rev Respir Med. 2020 Apr;14(4):353-365. doi: 10.1080/17476348.2020.1718495. Epub 2020 Jan 23.
3
A halotyrosine antibody that detects increased protein modifications in asthma patients.一种可检测哮喘患者蛋白质修饰增加的卤酪氨酸抗体。
J Immunol Methods. 2014 Jan 31;403(1-2):17-25. doi: 10.1016/j.jim.2013.11.013. Epub 2013 Dec 2.
4
Can sputum eosinophils predict a poor response to mepolizumab?痰液嗜酸性粒细胞能否预测对美泊利珠单抗反应不佳？
J Allergy Clin Immunol. 2024 Aug;154(2):280-281. doi: 10.1016/j.jaci.2024.04.013. Epub 2024 Apr 23.
5
For the Patient.给患者的。
Allergy Asthma Proc. 2018 Sep 1;39(5):398. doi: 10.2500/aap.2013.39.4170.
6
Efficacy of anti-interleukin-5 therapy with mepolizumab in patients with asthma: a meta-analysis of randomized placebo-controlled trials.抗白细胞介素-5 治疗药物美泊利珠单抗治疗哮喘的疗效：一项随机安慰剂对照试验的荟萃分析。
PLoS One. 2013;8(3):e59872. doi: 10.1371/journal.pone.0059872. Epub 2013 Mar 27.
7
Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.局部嗜酸性粒细胞生成过程在泼尼松依赖型重度哮喘气道嗜酸性粒细胞增多症发生中的作用
Clin Exp Allergy. 2016 Jun;46(6):793-802. doi: 10.1111/cea.12695.
8
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma.嗜酸性粒细胞衍生神经毒素与美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘的临床结局
Allergy. 2020 Aug;75(8):2085-2088. doi: 10.1111/all.14266. Epub 2020 Mar 23.
9
An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.一种抗 Siglec-8 抗体可从哮喘患者的痰中耗尽嗜酸性粒细胞，并抑制肺肥大细胞。
Clin Exp Allergy. 2020 Aug;50(8):904-914. doi: 10.1111/cea.13681. Epub 2020 Jul 8.
10
Mepolizumab: First Global Approval.美泊利珠单抗：全球首次获批
Drugs. 2015 Dec;75(18):2163-9. doi: 10.1007/s40265-015-0513-8.

引用本文的文献

1
Effectiveness of anti-IL-5/5Rα biologics in severe asthma in real-world studies: a systematic review and meta-analysis.抗IL-5/5Rα生物制剂在真实世界研究中治疗重度哮喘的有效性：一项系统评价和荟萃分析
ERJ Open Res. 2025 Mar 24;11(2). doi: 10.1183/23120541.00625-2024. eCollection 2025 Mar.
2
Galectin-10 as a Potential Biomarker for Eosinophilic Diseases.半乳糖凝集素-10 作为嗜酸性疾病的潜在生物标志物。
Biomolecules. 2022 Sep 27;12(10):1385. doi: 10.3390/biom12101385.